News
-
-
-
-
COMMUNIQUÉ DE PRESSE
NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-P
NanoBiotix annonce de nouveaux résultats de phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1 -
COMMUNIQUÉ DE PRESSE
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
Nanobiotix announces new results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in combination with immune checkpoint inhibitors as a 2L+ therapy for patients with primary cutaneous melanoma resistant to anti-PD-1. Favorable safety profile and early efficacy signals observed -
COMMUNIQUÉ DE PRESSE
CTS EVENTIM: LA28 announces tickets and hospitality packages will go on sale for the Olympic Games in 2026 and the Paralympic Games in 2027
AXS and EVENTIM announced as official supporter for the LA28 Olympic and Paralympic Games, offering ticketing options and hospitality packages for fans worldwide -
COMMUNIQUÉ DE PRESSE
Proof Positive: SMX and REDWAVE Validate Global Plastics Passport Framework for Flame-Retardant and Carbon-Black Plastics
SMX (NASDAQ:SMX) showcases real-time sorting and certification of challenging plastics, revolutionizing recycling standards with blockchain-backed traceability. Redefining global material economics -
-
-
